News & Event
21-24 April 2021
REVITALVISION will participate at the upcoming 41st ESA (EUROPEAN STRABISMOLOGICAL ASSOCIATION)
Meeting in PARIS 21th /24th April 2021
Link to article
2020
A New Adult Amblyopia study presented at AIOS 2020 (All India Ophthalmology Society)
meeting 2020 confirming again the efficacy of RevitalVision in improving vision in adult amblyopia
Download ppt
7 October
REVITALVISION will participate at the upcoming AAOPT (AMERICAN ACADEMY of OOPTOMETRY)
Meeting in Nashville, TN, USA 7-10 October
Link to article
2020
Tel Aviv Medical Center is recruiting Age related Macular Degeneration patients for a REVITALVISION clinical study
A Proof-of-Concept, Prospective, Open label, Randomized Clinical Study Evaluating RevitalVision® Therapy for Improving Best Corrected Visual Acuity (BCVA) and Contrast Sensitivity Function (CSF) in Patients Suffering from stabler Age related Macular Degeneration (AMD)
CONTÁCTENOS
Talshir Medical Technologies LTD
Hama’ayan Street 2, Modi’in 7177871, Israel
USA Phone: 1.800.361.8218 | Main Office: +972.77.212.3272
